Abstract
BackgroundTriple-negative breast cancers (TNBCs), especially those non-immune-inflamed tumors, have a poor prognosis and limited therapies. Human leukocyte antigen (HLA)-I not only contributes to antitumor immune response and the phenotype of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have